Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Isoniazid
CHF 43.30
Auf Lager
SKU
8M4H2CL7G2D
1 Verfügbar 
Geliefert zwischen Mi., 12.11.2025 und Do., 13.11.2025
Details
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Isoniazid (Laniazid, Nydrazid), also known as isonicotinylhydrazine (INH), is an organic compound that is the first-line antituberculosis medication in prevention and treatment. It was first discovered in 1912, and later in 1951 it was found to be effective against tuberculosis. Isoniazid is never used on its own to treat active tuberculosis because resistance quickly develops. The compound was first synthesised in the early 20th century, but its activity against tuberculosis was first reported in the early 1950''s and three pharmaceutical companies attempted unsuccessfully to simultaneously patent the drug (most prominently, Roche, who launched their version, Rimifon, in 1952). With the introduction of isoniazid, a cure for tuberculosis was first considered reasonable. Isoniazid is available in tablet, syrup, and injectable forms (given intramuscularly or intravenously). Isoniazid is available worldwide, is inexpensive and is generally well tolerated. It is manufactured from isonicotinic acid, which is produced from 4- methylpyridine.
Weitere Informationen
- Allgemeine Informationen
- GTIN 09786131603433
- Editor Frederic P. Miller, Agnes F. Vandome, John McBrewster
- Genre Chemie
- Größe H220mm x B220mm
- EAN 9786131603433
- Format Kartonierter Einband
- Titel Isoniazid
- Herausgeber Alphascript Publishing
- Anzahl Seiten 100
Bewertungen
Schreiben Sie eine Bewertung
